MS4A6C inhibitors represent a specific class of chemical agents that interact with and modulate the activity of the MS4A6C protein, which belongs to the membrane-spanning 4A (MS4A) family. The MS4A family of proteins is characterized by its structural configuration of four transmembrane domains, which facilitate various cellular processes related to signaling, ion transport, and membrane localization. MS4A6C, in particular, is encoded by a gene located on chromosome 11 and is expressed in certain cell types. The functional role of MS4A6C is not fully elucidated, but it is believed to be involved in regulating cellular communication and signal transduction across the plasma membrane. As with many membrane proteins, MS4A6C likely plays a role in interactions that influence downstream cellular activities, particularly those involving ion channel function and intracellular signaling cascades.
Inhibitors targeting MS4A6C are of particular interest in biochemical research because they allow for the modulation of the protein's function, enabling a deeper understanding of its role in cellular systems. These inhibitors typically operate by binding to specific domains of the MS4A6C protein, thereby altering its conformation or blocking its interaction with other cellular components. This disruption can lead to measurable changes in cell signaling pathways, membrane potential regulation, or other processes where MS4A6C is involved. By studying the effects of these inhibitors, researchers can gather insights into the broader functional network within which MS4A6C operates, helping to elucidate its exact contribution to cellular dynamics and signaling mechanisms. This knowledge can be further used to explore the protein's role in various biological contexts and provide a basis for understanding the complex molecular pathways influenced by the MS4A family of proteins.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
Disrupts protein transport by inhibiting ADP-ribosylation factor. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $152.00 $515.00 | ||
Ionophore that disrupts Golgi function by altering ion gradients. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $58.00 $83.00 $140.00 $242.00 | 38 | |
Destabilizes microtubules, affecting intracellular transport. | ||||||
Golgicide A | 1005036-73-6 | sc-215103 sc-215103A | 5 mg 25 mg | $187.00 $670.00 | 11 | |
Specific inhibitor of Golgi BFA resistance factor 1 (GBF1). | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
Inhibits N-linked glycosylation, affecting Golgi function. | ||||||
Swainsonine | 72741-87-8 | sc-201362 sc-201362C sc-201362A sc-201362D sc-201362B | 1 mg 2 mg 5 mg 10 mg 25 mg | $135.00 $246.00 $619.00 $799.00 $1796.00 | 6 | |
Inhibits Golgi alpha-mannosidase II, affecting glycoprotein processing. | ||||||
Castanospermine | 79831-76-8 | sc-201358 sc-201358A | 100 mg 500 mg | $180.00 $620.00 | 10 | |
Inhibits glucosidases, impacting glycoprotein folding in the ER/Golgi. | ||||||
Tyrphostin AG 1478 | 175178-82-2 | sc-200613 sc-200613A | 5 mg 25 mg | $94.00 $413.00 | 16 | |
EGFR tyrosine kinase inhibitor, affecting signaling and trafficking. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $65.00 $210.00 | 26 | |
Inhibits glycolysis and glycosylation processes. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Raises lysosomal pH, affecting protein degradation and trafficking. | ||||||